You have read all your free articles, to continue reading subscribe to read the rest of this content.
Ascendis Pharma has announced data supporting its product pipeline presented at ENDO 2017, the annual meeting of the Endocrine Society in Orlando, Florida. "We are delighted to show the breadth of our growing pipeline at this year's ENDO conference, including three potentially differentiated treaAlready a subscriber Login You have read…
The AstraZeneca trial met primary endpoint of objective response rate and key secondary endpoint of overall survival in patients with previously treated HER2-positive metastatic gastric cancer. Results from the positive registrational Phase II trial DESTINY-Gastric01 showed AstraZeneca’s and DaAlready a subscriber Login You have read all your free articles, to…
Vicore Pharma Holding has announced plans to initiate a clinical trial with C21 in Pulmonary arterial hypertension. Pulmonary arterial hypertension (PAH) is a rare lung disease with huge unmet medical need where existing medicines reduce the pressure by dilating the vessels without changing underAlready a subscriber Login You have read…
Onxeo S.A.’s Validive®’s (clonidine Lauriad®) phase II clinical trial results have been accepted for an oral presentation at the MASCC/ISOO International Symposium scheduled for June 25-27 in Copenhagen. The company specializes in the development of orphan oncology drugs. The MASCC/ISOO Already a subscriber Login You have read all your free…
